Danish biotech firm Biograil, founded by two former Egalet researchers, has entered a partnership with major pharmaceutical company Janssen and is poised to raise new capital.
It's unfortunate for hearing aid company Demant that the launch of the firm's new flagship manufacturer coincides with the greatest crisis in the history of the industry. But experiences based on the last nine months in Covid-19 alertness cause CEO Søren Nielsen to trust in a successful launch.
Lundbeck adjusts its EBIT guidance after the Danish Business Authority ordered a reassessment of the impairment.
French pharmaceutical company Sanofi has won a case at the Danish Maritime and Commercial Court on Novo Nordisk's home ground on violations of Marketing Practices Act.
With several scheduled launches, Incyte Biosciences is in a hurry to expand the organization's local departments. This is also the case in the Nordics, where the General Manager Erik Fromm expects to double the firm's employees.
Kristian Villumsen has great ambitions on behalf of Coloplast and is set on having the company grow even more. Behind the scenes, the idea of complacency worries him sick.
Hearing aid giant Demant has new flagship product ready, which has been rumored to replace the success Oticon Opn. On Monday, the firm also announces new products in three of its other brands.
As the market awaits clarification on whether Novo Nordisk will move into the market for Alzheimer's treatments, the pharmaceutical firm embarks on a hunt for an executive position with this disease as one of its focus areas.
Danish firm Advanced Bionics has had a smaller revenue and has generated a smaller income than the year before. Having lost last year's tender for implants, the company continues to struggle and now survives at the mercy of its owner, which has promised to support it for a year, starting at the time of the fiscal report in March.
The EU Commission wants to give Europeans more affordable and more accessible medicines, and then the European pharmaceutical industry needs to be strengthened and the safety of the supply chains needs to be top-notch next time we face a pandemic.
Biotech firm ISD Immunotech has entered into collaboration with US Biogen to develop the Danish firm's drug candidate for the autoimmune disease Lupus. If everything goes well, the drug can go on a market in 2028.
The biotech firm genmab shelves cancer project which US J.P. Morgen predicted would have sales potential at USD 2bn per year.
After getting listed on the US stock exchange, Galecto has gained the former CEO of Aimmune Therapeutics, which was acquired by Nestlé's health division earlier in the year.
Few other firms have been on the front lines of the Covid-19 pandemic to the same extent that healthtech firm Philips has, with the crisis causing marked organizational changes in the Nordic business, while infection rates were at a high.
The competition for the US sales channel Veteran Affairs is increasing, and in November, the three Danish hearing aid giants Demant, GN Hearing and WS Audiology have either launched new top products or improved existing ones in attempts to win market shares in this channel, which holds 20 percent of all hearing aid sales on the world's largest market.
A court strife between Novo Nordisk and Biomarin on business secrets and the recruitment of central Novo Nordisk employees has been concluded outside of court, according to Børsen.
A dose of Moderna's Covid-19 vaccine, which will be ready very soon, will cost between USD 25 and USD 37.
Two senators responsible for the legislation concerning over-the-counter hearing aid sales in the US are once again addressing the FDA, now demanding that the authority introduces the public and hearing aid industry to the framework surrounding future hearing aid sales - "without further delay".
Mediq has entered an alliance with award-winning medtech firm O2matic to distribute the startup's robot for oxygen treatment in a series of Northern European countries, where it might prove useful for the treatment of Covid-19.
Novo Nordisk cuts 450 positions in the US based on a desire to "ensure long-term sustainable growth on the US market". The exact amount of people being fired is still unclear.
The former CEO of the hearing aid manufacturer Widex, Jørgen Jensen, sees no issue with chairing four companies following his nomination to be the new chairman of the board at Ambu on Friday.
The market leader Sonova's progress came to a halt when faced with US war veterans in October, when Demant and GN Hearing also lost market shares at the cost of US Starkey and the merger firm WS Audiology.
Pila Pharma has scheduled its arrival on the Swedish stock market for May next year with the goal of fetching SEK 50m for developing the firm's diabetes tablet leading up to phase III.
Ambu faces increased competition as a new major player might be entering single-use endoscope market next year. CEO Juan Jose Gonzalez has an answer ready for the increasing competition, which is that of lowering the price of single-use endoscopes.
Irishwoman Emer Cooke officially took up office as the executive director of the European Medicines Agency on Monday, and much is expected of her after 10 years with her predecessor Guido Rasi. A woman on the post and a modernized management style will take the EMA to a new era, according to some.
